[Effect of endolymphatic I-131 therapy on proteins and cellular components of human blood].
D001773:Blood Cells / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D007456:Iodine Isotopes / Q000008:administration & dosage* / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008259:Macroglobulins / Q000032:analysis; D012186:Retroperitoneal Neoplasms / Q000532:radiotherapy; D014168:Transferrin / Q000032:analysis; D014361:Trypsin Inhibitors / Q000032:analysis; D005719:gamma-Globulins / Q000032:analysis
D001798:Blood Proteins; D006023:Glycoproteins; D006242:Haptoglobins; D007456:Iodine Isotopes; D008259:Macroglobulins; D014168:Transferrin; D014361:Trypsin Inhibitors; D005719:gamma-Globulins
Auswirkungen der endolymphatischen 131 J-Therapie auf Proteine und Zelluläre Bestandteile des menschlichen Blutes.